LONG-TERM (UP TO 5 YEARS) PERSISTENCE WITH DIFFERENT ANTI-OSTEOPOROSIS MEDICATIONS IN CATALONIA (SPAIN): A POPULATION-BASED COHORT STUDY

被引：0
|
作者：
Carbonell-Abella, C. [1 ,2 ]
Nogues, X. [3 ]
Pages-Castella, A. [2 ]
Diez-Perez, A. [3 ]
Prieto-Alhambra, D. [4 ]
机构：
[1] Inst Catala Salut, Barcelona, Spain
[2] IDIAP Jordi Gol, Barcelona, Spain
[3] IMIM Parc Salut Mar, Musculoskeletal Res Unit, Barcelona, Spain
[4] Univ Oxford, IMIM Parc Salut Mar, NDORMS, Barcelona, Spain
来源：
OSTEOPOROSIS INTERNATIONAL | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P529
引用
下载
收藏
页码：S357 / S357
页数：1
相关论文
共 50 条
  • [21] Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study
    Wu, Y. -C.
    Chen, S.
    Wu, P. -L.
    Tsou, H. -K.
    Wei, J. C. -C.
    JOURNAL OF INTERNAL MEDICINE, 2022, 291 (03) : 384 - 385
  • [22] Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study
    Fu, Shau-Huai
    Wang, Chen-Yu
    Hung, Chih-Chien
    Lee, Chia-Che
    Yang, Rong-Sen
    Huang, Chuan-Ching
    Farn, Chui-Jia
    Lin, Wei-Hsin
    Chen, Ho-Min
    Hsiao, Fei-Yuan
    Lin, Jou-Wei
    Li, Chung-Yi
    JOURNAL OF INTERNAL MEDICINE, 2021, 290 (06) : 1194 - 1205
  • [23] COMPARATIVE ANTI-FRACTURE EFFECTIVENESS OF DIFFERENT ANTI-OSTEOPOROSIS MEDICATIONS AMONGST MALE DRUG USERS IN REAL WORLD CLINICAL PRACTICE: A POPULATION-BASED COHORT STUDY
    Zwart, M.
    Hawley, S.
    Van Staa, T.
    Harvey, N.
    Judge, A.
    Javaid, M. K.
    Cooper, C.
    Prieto-Alhambra, D.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S124 - S125
  • [24] Risk, determinants, and persistence of long-COVID in a population-based cohort study in Catalonia
    Manolis Kogevinas
    Marianna Karachaliou
    Ana Espinosa
    Susana Iraola-Guzmán
    Gemma Castaño-Vinyals
    Laura Delgado-Ortiz
    Xavier Farré
    Natàlia Blay
    Neil Pearce
    Magda Bosch de Basea
    Eva Alonso Nogués
    Carlota Dobaño
    Gemma Moncunill
    Rafael de Cid
    Judith Garcia-Aymerich
    BMC Medicine, 23 (1)
  • [25] USE OF ANTI-OSTEOPOROSIS DRUGS IN TYPE 2 DIABETIC PATIENTS: A POPULATION-BASED COHORT STUDY
    Martinez-Laguna, D.
    Carbonell-Abella, C.
    Soria-Castro, A.
    Nogues, X.
    Diez-Perez, A.
    Prieto-Alhambra, D.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S159 - S159
  • [26] Long-term exposure to air pollution and severe COVID-19 in Catalonia: a population-based cohort study
    Otavio Ranzani
    Anna Alari
    Sergio Olmos
    Carles Milà
    Alex Rico
    Joan Ballester
    Xavier Basagaña
    Carlos Chaccour
    Payam Dadvand
    Talita Duarte-Salles
    Maria Foraster
    Mark Nieuwenhuijsen
    Jordi Sunyer
    Antònia Valentín
    Manolis Kogevinas
    Uxue Lazcano
    Carla Avellaneda-Gómez
    Rosa Vivanco
    Cathryn Tonne
    Nature Communications, 14
  • [27] Long-term exposure to air pollution and severe COVID-19 in Catalonia: a population-based cohort study
    Ranzani, Otavio
    Alari, Anna
    Olmos, Sergio
    Mila, Carles
    Rico, Alex
    Ballester, Joan
    Basagana, Xavier
    Chaccour, Carlos
    Dadvand, Payam
    Duarte-Salles, Talita
    Foraster, Maria
    Nieuwenhuijsen, Mark
    Sunyer, Jordi
    Valentin, Antonia
    Kogevinas, Manolis
    Lazcano, Uxue
    Avellaneda-Gomez, Carla
    Vivanco, Rosa
    Tonne, Cathryn
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [28] Apgar score and long-term respiratory morbidity of the offspring: a population-based cohort study with up to 18 years of follow-up
    Elisha Ernest
    Tamar Wainstock
    Eyal Sheiner
    Idit Segal
    Daniella Landau
    Asnat Walfisch
    European Journal of Pediatrics, 2019, 178 : 403 - 411
  • [29] A population-based study of dosing and persistence with anti-dementia medications
    Linda Brewer
    Kathleen Bennett
    Cora McGreevy
    David Williams
    European Journal of Clinical Pharmacology, 2013, 69 : 1467 - 1475
  • [30] A population-based study of dosing and persistence with anti-dementia medications
    Brewer, Linda
    Bennett, Kathleen
    McGreevy, Cora
    Williams, David
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (07) : 1467 - 1475
12345